BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37573011)

  • 1. MSC.sensor: Capturing cancer cell interactions with stroma for functional profiling.
    Huang Y; Drakul A; Sidhu J; Rauwolf KK; Kim J; Bornhauser B; Bourquin JP
    SLAS Discov; 2023 Oct; 28(7):350-354. PubMed ID: 37573011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
    Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
    BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MSC and HSPC Coculture: Mimicking Ex Vivo Bone Marrow Niche.
    Singh P
    Methods Mol Biol; 2023; 2567():181-189. PubMed ID: 36255702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment.
    Vernot JP; Bonilla X; Rodriguez-Pardo V; Vanegas NP
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menatetrenone facilitates hematopoietic cell generation in a manner that is dependent on human bone marrow mesenchymal stromal/stem cells.
    Fujishiro A; Iwasa M; Fujii S; Maekawa T; Andoh A; Tohyama K; Takaori-Kondo A; Miura Y
    Int J Hematol; 2020 Sep; 112(3):316-330. PubMed ID: 32572826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
    Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
    Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of oxygen concentration on growth of mesenchymal stromal cells from the marrow of patients with chronic lymphocytic leukemia.
    Fecteau JF; Messmer D; Zhang S; Cui B; Chen L; Kipps TJ
    Blood; 2013 Feb; 121(6):971-4. PubMed ID: 23255557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer cell-soluble factors reprogram mesenchymal stromal cells to slow cycling, chemoresistant cells with a more stem-like state.
    El-Badawy A; Ghoneim MA; Gabr MM; Salah RA; Mohamed IK; Amer M; El-Badri N
    Stem Cell Res Ther; 2017 Nov; 8(1):254. PubMed ID: 29115987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: correlations with the course of disease.
    Vicente López Á; Vázquez García MN; Melen GJ; Entrena Martínez A; Cubillo Moreno I; García-Castro J; Orellana MR; González AG
    PLoS One; 2014; 9(1):e84496. PubMed ID: 24400095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close interaction with bone marrow mesenchymal stromal cells induces the development of cancer stem cell-like immunophenotype in B cell precursor acute lymphoblastic leukemia cells.
    Kihira K; Chelakkot VS; Kainuma H; Okumura Y; Tsuboya N; Okamura S; Kurihara K; Iwamoto S; Komada Y; Hori H
    Int J Hematol; 2020 Dec; 112(6):795-806. PubMed ID: 32862292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALL.
    Balandrán JC; Dávila-Velderrain J; Sandoval-Cabrera A; Zamora-Herrera G; Terán-Cerqueda V; García-Stivalet LA; Limón-Flores JA; Armenta-Castro E; Rodríguez-Martínez A; Leon-Chavez BA; Vallejo-Ruiz V; Hassane DC; Pérez-Tapia SM; Ortiz-Navarrete V; Guzman ML; Pelayo R
    Front Immunol; 2021; 12():746492. PubMed ID: 34737747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent Pro-Tumorigenic Shift in Adipose Tissue-Derived Mesenchymal Stromal Cells Induced by Breast Malignancy.
    Plava J; Cihova M; Burikova M; Bohac M; Adamkov M; Drahosova S; Rusnakova D; Pindak D; Karaba M; Simo J; Mego M; Danisovic L; Kucerova L; Miklikova S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32093026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments.
    Stamatopoulos B; Meuleman N; De Bruyn C; Pieters K; Mineur P; Le Roy C; Saint-Georges S; Varin-Blank N; Cymbalista F; Bron D; Lagneaux L
    Haematologica; 2012 Apr; 97(4):608-15. PubMed ID: 22058221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer.
    Sung SY; Liao CH; Wu HP; Hsiao WC; Wu IH; Jinpu ; Yu ; Lin SH; Hsieh CL
    PLoS One; 2013; 8(8):e71637. PubMed ID: 23977098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival.
    Trimarco V; Ave E; Facco M; Chiodin G; Frezzato F; Martini V; Gattazzo C; Lessi F; Giorgi CA; Visentin A; Castelli M; Severin F; Zambello R; Piazza F; Semenzato G; Trentin L
    Oncotarget; 2015 Dec; 6(39):42130-49. PubMed ID: 26517523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.
    Hu K; Gu Y; Lou L; Liu L; Hu Y; Wang B; Luo Y; Shi J; Yu X; Huang H
    J Hematol Oncol; 2015 Jan; 8():1. PubMed ID: 25622682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors.
    Chandran P; Le Y; Li Y; Sabloff M; Mehic J; Rosu-Myles M; Allan DS
    Leuk Res; 2015 Apr; 39(4):486-93. PubMed ID: 25703353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs.
    Benjamin ESB; Vinod E; Illangeswaran RSS; Rajamani BM; Vidhyadharan RT; Bagchi A; Maity A; Mohan A; Parasuraman G; Amirtham SM; Abraham A; Velayudhan SR; Balasubramanian P
    Cell Signal; 2024 Apr; 116():111067. PubMed ID: 38281615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
    Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
    J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).
    Martin FT; Dwyer RM; Kelly J; Khan S; Murphy JM; Curran C; Miller N; Hennessy E; Dockery P; Barry FP; O'Brien T; Kerin MJ
    Breast Cancer Res Treat; 2010 Nov; 124(2):317-26. PubMed ID: 20087650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.